HomePress ReleaseEIN PresswireAsymmetrex® Talks with Tech Company News about New Stem Cell Calculators

Asymmetrex® Talks with Tech Company News about New Stem Cell Calculators

Tech Company News Oct 31 Prime News: Interview with Asymmetrex®

Tech Company News editors interview Asymmetrex® to study extra about the corporate’s introduction of free stem cell calculators.

The 5 calculators we simply launched are the tip of a really superb iceberg of know-how.”

— James L. Sherley, Asymmetrex® CEO

BOSTON, MA, USA, November 2, 2023 / — Earlier this week, the editors of Tech Company News revealed an interview with Asymmetrex® President and CEO, James L. Sherley, M.D., Ph.D., about his firm’s most up-to-date advance indicative of its tagline, “Applied sciences for Stem Cell Medication.”

Earlier this month on its firm web site, Asymmetrex® started offering on-line, prompt calculators that permit anybody with the flexibility to carry out easy cell tradition procedures to quickly decide the variety of tissue stem cells of their samples. The corporate is making the brand new calculators accessible with minimal limitations to make use of, together with no value.

4 of the 5 newly accessible calculators are specified for 4 totally different sources of human blood stem cells, and one can be utilized to quantify stem cells present in fats tissue. The 4 coated blood stem sources embody two generally used umbilical wire blood preparations and two sources of grownup blood stem cells, that are bone marrow and peripheral blood apheresis donations.

Although all 4 blood stem cell sources are used for authorized stem cell transplant therapies for childhood and grownup cancers, beforehand, treating physicians haven’t had a check to make sure a ample stem cell dosage earlier than they transplant sufferers. Having this long-needed dosage information, which Asymmetrex®’s calculators present for the primary time, can stop failures of transplant remedies due to too few stem cells.

The anticipated impression of the brand new calculators for stem cell science and drugs communities was self-evident to the editors of TCN. Nonetheless, it was not initially clear how offering the calculators for-free match into Asymmetrex®’s commercialization plans.

Sherley defined that “The 5 calculators we simply launched are the tip of a really superb iceberg of know-how.” He shared with TCN that lots of of further fast stem cell-counting calculators exist for Asymmetrex® to customise for a lot of totally different tissue stem cell sources below many various stem cell tradition situations. The universe of calculators for tissue stem cell analysis, stem cell drugs, cell biomanufacturing, and pharmaceutical drug improvement purposes is an intensive one. Due to the numerous important roles stem cells play in well being and illness, the vary of impression additionally consists of pet and livestock drugs, most cancers drugs, and even growing older analysis.

Within the firm’s commercialization imaginative and prescient, the free calculators proceed to construct the inspiration for its longer-term plan of producing and advertising the primary tissue stem cell counting devices. These automated digital tissue stem cell counters shall be powered by finely tuned proprietary calculators that rely every proprietor’s particular stem cell sorts below a wide range of specialised stem cell tradition situations which are essential for them. Sherley reminded TCN that the free calculators had been simply the newest step in reaching his firm’s plan to change into the primary supplier of future tissue stem cell counters, which he sees “on each tissue cell analysis lab bench, in each stem cell transplantation heart, in each cell biomanufacturing firm, and in each pharmaceutical drug analysis division.”

About Asymmetrex®

Asymmetrex®, LLC is a U.S. life sciences firm with a deal with growing applied sciences to advance stem cell drugs. The corporate’s U.S. and U.Ok. patent portfolio accommodates biotechnologies that clear up the 2 primary technical issues – stem cell-specific quantification and stem cell enlargement – which have stood in the way in which of more-effective use of human grownup tissue stem cells for regenerative drugs and drug improvement. Asymmetrex markets kinetic stem cell (KSC) counting, the primary know-how for willpower of the dose and high quality of tissue stem cell preparations to be used in stem cell transplantation drugs and pre-clinical drug evaluations. Asymmetrex® is a member firm of the Superior Regenerative Manufacturing Institute (ARMI)|BioFabUSA. The corporate’s improvement of fast stem cell counting applied sciences has been funded by R&D grants from ARMI|BioFabUSA and the Nationwide Coronary heart, Lung, and Blood Institute.

James L. Sherley, M.D., Ph.D.
Asymmetrex® LLC
+1 617-990-6819
e-mail us right here
Go to us on social media:

Asymmetrex®’s Kinetic Stem Cell (KSC) Counting Applied sciences


Most Popular